TGF-β1-containing exosomes from cardiac microvascular endothelial cells mediate cardiac fibroblast activation under high glucose conditions
Authors:
- 1 December 2021
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 99 (6) , 693-699
Abstract
Cardiac fibroblast (CF)-mediated extracellular matrix (ECM) remodeling is the key pathological basis for the occurrence and development of diabetic cardiomyopathy (DCM); its specific regulatory mechanisms have been widely studied but remain unclear. Exosomes are a type of stable signal transmission medium, and exosome-mediated cell-cell interactions play an important role in DCM. Endothelial cells form an important barrier between circulation and cardiomyocytes, in addition to being an important endocrine organ of the heart and an initial target for hyperglycemia, a key aspect in the development of DCM. We previously showed that exosomes derived from cardiac microvascular endothelial cells (CMECs) under high glucose conditions can be taken up by cardiomyocytes and regulate autophagy, apoptosis, and glucose metabolism. Consequently, in the present study, we focused on how exosomes mediate the interaction between CMECs and CFs. Surprisingly, exosomes derived from CMECs under high glucose were rich in TGF-β1 mRNA, which significantly promoted the activation of CFs. Additionally, exosomes derived from CMECs under high glucose conditions aggravated perivascular and interstitial fibrosis in mice treated with streptozotocin. Herein, we demonstrated for the first time the capacity of exosomes, released by CMECs under high glucose, to mediate fibroblast activation through TGF-β1 mRNA, which may be potentially beneficial in the development of exosome-targeted therapies to control DCM.Keywords
This publication has 34 references indexed in Scilit:
- Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic DiseaseTrends in Endocrinology & Metabolism, 2017
- Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunctionScientific Reports, 2016
- Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic MiceDiabetes, 2016
- TGF-β: the master regulator of fibrosisNature Reviews Nephrology, 2016
- Extracellular matrix structureAdvanced Drug Delivery Reviews, 2016
- Cardiac fibroblasts: from development to heart failureJournal of Molecular Medicine, 2015
- Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypesEuropean Heart Journal, 2015
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular VesiclesAnnual Review of Cell and Developmental Biology, 2014
- Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathyEuropean Heart Journal, 2014
- TGF-β1–Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and FibrosisJournal of the American Society of Nephrology, 2013